Free Trial
NASDAQ:CHEK

Check-Cap (CHEK) Stock Price, News & Analysis

$2.00
-0.02 (-0.99%)
(As of 11:33 AM ET)
Today's Range
$1.98
$2.01
50-Day Range
$1.92
$2.30
52-Week Range
$1.78
$4.63
Volume
1,033 shs
Average Volume
123,084 shs
Market Capitalization
$11.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CHEK stock logo

About Check-Cap Stock (NASDAQ:CHEK)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

CHEK Stock Price History

CHEK Stock News Headlines

Check Point: This Will Likely Be 'Dead Money' For Some Time
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Why Is Check-Cap (CHEK) Stock Up 44% Today?
Larger than expected salary cap means more space for Jaguars
Check Cap Ltd (CHEK)
See More Headlines
Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/25/2024
Next Earnings (Estimated)
8/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Current Symbol
NASDAQ:CHEK
Employees
85
Year Founded
N/A

Profitability

Net Income
$-17,570,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.05 per share

Miscellaneous

Free Float
5,823,000
Market Cap
$11.82 million
Optionable
Not Optionable
Beta
0.40
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Yoav Kimchy Ph.D. (Age 63)
    Founder & Interim CTO
    Comp: $362.65k
  • Mr. Joshua Belkar (Age 55)
    Vice President of Operations
    Comp: $269.57k
  • Mr. Saar Levi (Age 57)
    Interim Chief Executive Officer
  • Ms. Iris Even-Tov (Age 54)
    Interim Chief Financial Officer
  • Ms. Noa Reshef M.B.A.
    Director of Human Resources

CHEK Stock Analysis - Frequently Asked Questions

How have CHEK shares performed this year?

Check-Cap's stock was trading at $2.08 on January 1st, 2024. Since then, CHEK stock has decreased by 2.9% and is now trading at $2.02.
View the best growth stocks for 2024 here
.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Wednesday, May, 15th. The medical research company reported ($0.62) EPS for the quarter.

When did Check-Cap's stock split?

Check-Cap shares reverse split on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Check-Cap IPO?

Check-Cap (CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Check-Cap own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD) and Acasti Pharma (ACST).

This page (NASDAQ:CHEK) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners